MedWatch

Thirstrup: EMA more welcoming towards the industry

Increased sparring with EU top drug agency, EMA, is going to help pharmaceutical companies to design their studies just right, says former top advisor, Steffen Thirstrup.

Medwatch morning meeting

There is help on the way to the drug industry from the European Medicines Agency (EMA). In a time of shaved-down health budgets, the EMA will increase its counselling efforts to the industry concerning how drug trials should be designed in order to be successful.

That was one of the main bullet-points when Steffen Thirstrup, former head of medicines approvals in Denmark and current advisor for the major European consultant firm, NDA, spoke at the first ever Medwatch morning meeting on Friday.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier